Background. This study explored the efficacy of the “L-sandwich” strategy, which involves the implantation of stents in the main vessel (MV) and shaft of the side branch (SB) with a drug-coated balloon (DCB) applied to the SB ostium, for coronary true bifurcation lesions. Methods and Results. Of 99 patients with true bifurcation lesions, 38 patients underwent the “L-sandwich” strategy (group A), 32 patients underwent a two-stent strategy (group B), and 29 patients underwent a single-stent + DCB strategy (group C). Angiography outcomes (late lumen loss [LLL], minimum lumen diameter [MLD]), and clinical outcomes (major adverse cardiac events [MACEs]) were analyzed. At 6 months, the MLD of the SB ostium in groups A and B were similar ( ) and group A larger than group C ( ). The LLL of group B was the largest among the three groups ( ). The MLD of the SB shaft in groups A and B were larger than in group C ( ). The LLL of the SB shaft in group C was the lowest ( ). Two patients in group B received target vessel revascularization at the 6-month followup ( ), and patients in the other groups had no MACEs. Conclusions. The “L-sandwich” strategy was feasible for the treatment of true coronary bifurcation lesions. It is a simpler procedure with similar acute lumen gain than the two-stent strategy, results in a larger SB lumen than the single-stent + DCB strategy, and it can also be used as a remedy for dissection following the single-stent + DCB strategy.
3 February 2026 in IEEE Transactions on Consumer Electronics
Consumer-Centric Digital Twins (CCDT) are emerging as transformative enablers in Healthcare 5.0, offering real-time monitoring, predictive analytics, and patient-specific treatment optimization. This paper introduces CardioTwin-XAI, a novel AI-driven CCDT framework designed for early detection, risk prediction, and personalized management of Coronary Artery Disease (CAD) and related conditions such as atherosclerosis, myocardial infarction (MI), and heart failure (HF). The proposed system integrates IoT-enabled wearable sensors, continuous hemodynamic profiling, and federated multimodal learning to build a dynamic, patient-specific digital replica. The key innovation of CardioTwin-XAI is its unified integration of explainable AI (XAI) with privacy-preserving federated learning, wherein interpretable attribution mechanisms are embedded within distributed model updates, enabling transparent predictions without compromising data confidentiality across healthcare institutions. A hybrid transformer-GNN architecture captures complex spatiotemporal cardiovascular dynamics, while differential privacy and blockchain-based data sharing ensure regulatory compliance. Evaluation on multi-institutional datasets demonstrates 92.6% accuracy in CAD prediction, 31% improvement in treatment planning efficiency, and 40% reduction in unnecessary interventions. The proposed framework paves the way for scalable, secure, and explainable cardiovascular care in next-generation healthcare ecosystems.
Even in individuals without diabetes, the incidence of coronary heart disease (CHD) increases with the rise in fasting plasma glucose (FPG); however, the threshold of FPG for CHD in rural areas of China is unclear. We retrospectively examined 2,987 people. Coronary angiography records were used to determine the presence of CHD as well as its severity. Risk factors for CHD and the relationship between different levels of FPG and CHD were analyzed. After adjusting for age, hypertension, dyslipidemia, smoking, drinking, chronic kidney disease, and previous ischemic stroke, the incidence of CHD in nondiabetic women began to increase when FPG exceeded 5.2 mmol/L (odds ratio (OR) = 1.438, 95% confidence interval (CI) = 1.099–1.880, p = 0.008), and the degree of coronary artery lesions also became more severe (OR = 1.406, 95% CI = 1.107–1.788, p = 0.005). However, no such correlations were found in nondiabetic men. In conclusion, among the nondiabetic women in rural areas of northern Henan, both the incidence of CHD and the severity of lesions increased when FPG levels were greater than 5.2 mmol/L, while no significant correlation between FPG and CHD was observed in diabetes‐free men.
24 February 2026 in IEEE Transactions on Consumer Electronics
Cardiovascular diseases (CVDs) are the most common causes of death in the world, especially coronary artery disease (CAD) and heart failure (HF). Prevention and sustained monitoring in the early stages are essential, yet conventional diagnostic methods are expensive, invasive, and limited to the clinical environment. Recent developments in consumer electronics (CE), including smartwatches and smartphones, are providing new opportunities for real-time, non-invasive cardiovascular monitoring. Nevertheless, the implementation of deep learning (DL) on such devices poses challenges for explainability, computational efficiency, and privacy. This paper introduces CardioGPT-ViT, a novel multimodal, explainable DL model for detecting CAD and HF on edge devices. The model combines Vision Transformers (ViT), GPT-style attention, Mamba state-space modeling, and a small You Only Look Once (YOLO) detection head and incorporates the explainability functionality of clinical trust. CardioGPT-ViT was trained and tested on three benchmark datasets: PulseDB, UCI Heart Disease, and an external electrocardiography (ECG)/photoplethysmography (PPG) cohort. The framework includes SHapley Additive exPlanations (SHAP), Local explainable Model-Agnostic Explanation (LIME), attention maps, and Gradient-weighted Class Activation Mapping (Grad-CAM) to explain results. Quantization, pruning, and latency/energy profiling were used to verify the feasibility of edge deployment on consumer devices. It was compared to performance with recent baseline models across convolutional neural networks (CNNs), ViTs, and state-space architectures. CardioGPT-ViT also scored over 0.90 across all datasets, reaching a maximum of 0.962 on PulseDB. The model was found to be more accurate (92.8%) and robust and had real-time feasibility (latency of less than 50 ms) and low energy consumption (less than 80 mJ per inference). Explainability results correlated with clinical biomarkers, increasing trust. CardioGPT-ViT provides a clinically explainable, resource-efficient, and edge-deployable solution to next-generation cardiovascular care, connecting the gap between consumer electronics and long-term preventive healthcare.
Background: Insomnia is a prevalent sleep disorder increasingly recognized as a risk factor for cardiovascular diseases (CVDs). However, its causal relationship with myocardial infarction (MI) and its impact on coronary plaque vulnerability remain poorly understood. Methods: We performed Mendelian randomization (MR) analysis using genome‐wide association study (GWAS) summary data for insomnia ( n = 462,341) and MI ( n = 484,598) in populations of European descent. Additionally, 340 patients with coronary artery disease (CAD) underwent coronary angiography and optical coherence tomography (OCT) imaging. Insomnia was assessed by the Insomnia Severity Index (ISI), and OCT was used to evaluate plaque features including thin‐cap fibroatheroma (TCFA), fibrous cap thickness, lipid arc, macrophage infiltration, and plaque rupture. Results: MR analysis showed a potential causal effect of genetically predicted insomnia on MI risk (OR = 1.015; 95% CI: 1.004–1.027; p = 0.007), with no evidence of pleiotropy or heterogeneity. Clinically patients with insomnia (ISI ≥ 8) had higher rates of hypertension (54.3% vs. 39.6%) and MI (32.4% vs. 21.7%), elevated CRP levels, and exhibited greater plaque vulnerability on OCT, including increased incidence of TCFA (29.5% vs. 17.0%), thinner fibrous caps, larger lipid arcs, and more frequent macrophage infiltration and plaque rupture. Logistic regression identified both insomnia (OR = 1.806; p = 0.037) and CRP (OR = 1.384; p = 0.034) as independent predictors of TCFA. Conclusions: This study provides genetic and clinical evidence that insomnia contributes to MI risk and coronary plaque vulnerability, underscoring the importance of addressing sleep disturbances in CAD management.